Evidence map›Paper›PMID 31707811›Full record

ArticleCirculation. Cardiovascular imaging2019

Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic

Stephanie L Thorn, Shayne C Barlow, Attila Feher, Mitchel R Stacy, Heather Doviak, Julia Jacobs, Kia Zellars, Jennifer M Renaud, Ran Klein, Robert A deKemp and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Cardiovascular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. LncRNA KCNQ1OT1 aggravates myocardial ischemia/reperfusion injury by mediating the EZH2/TIMP-3 axis.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Potential novel imaging targets of inflammation in cardiac sarcoidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Modulation of Cardiac Fibrosis in and Beyond Cells.Frontiers in molecular biosciences · 2021
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Stephanie L ThornSection of Cardiovascular Medicine, Department of Internal Medicine (S.L.T., A.F., M.R.S., A.J.S.), Yale University, School of Medicine, New Haven, CT.
Shayne C BarlowDepartment of Cell Biology and Anatomy, Surgery, Cardiovascular Translational Research Center, WJB Dorn Veteran Affairs Medical Center, University of South Carolina School of Medicine, Columbia (S.C.B., H.D., J.J., K.Z., F.G.S.).
Attila FeherSection of Cardiovascular Medicine, Department of Internal Medicine (S.L.T., A.F., M.R.S., A.J.S.), Yale University, School of Medicine, New Haven, CT.
Mitchel R StacySection of Cardiovascular Medicine, Department of Internal Medicine (S.L.T., A.F., M.R.S., A.J.S.), Yale University, School of Medicine, New Haven, CT.
Heather DoviakDepartment of Cell Biology and Anatomy, Surgery, Cardiovascular Translational Research Center, WJB Dorn Veteran Affairs Medical Center, University of South Carolina School of Medicine, Columbia (S.C.B., H.D., J.J., K.Z., F.G.S.).
Julia JacobsDepartment of Cell Biology and Anatomy, Surgery, Cardiovascular Translational Research Center, WJB Dorn Veteran Affairs Medical Center, University of South Carolina School of Medicine, Columbia (S.C.B., H.D., J.J., K.Z., F.G.S.).
Kia ZellarsDepartment of Cell Biology and Anatomy, Surgery, Cardiovascular Translational Research Center, WJB Dorn Veteran Affairs Medical Center, University of South Carolina School of Medicine, Columbia (S.C.B., H.D., J.J., K.Z., F.G.S.).
Jennifer M RenaudDivision of Cardiology, University of Ottawa Heart Institute, ON, Canada (J.M.R., R.K., R.dK.).
Ran KleinDivision of Cardiology, University of Ottawa Heart Institute, ON, Canada (J.M.R., R.K., R.dK.).
Robert A deKempDivision of Cardiology, University of Ottawa Heart Institute, ON, Canada (J.M.R., R.K., R.dK.).
Aarif Y KhakooAmgen, CardioMetabolic Disorders, South San Francisco, CA (A.Y.K., T.W.).
TaeWeon LeeAmgen, CardioMetabolic Disorders, South San Francisco, CA (A.Y.K., T.W.).
Francis G SpinaleDepartment of Cell Biology and Anatomy, Surgery, Cardiovascular Translational Research Center, WJB Dorn Veteran Affairs Medical Center, University of South Carolina School of Medicine, Columbia (S.C.B., H.D., J.J., K.Z., F.G.S.).
Albert J SinusasSection of Cardiovascular Medicine, Department of Internal Medicine (S.L.T., A.F., M.R.S., A.J.S.), Yale University, School of Medicine, New Haven, CT.
Yale University · USUniversity of Ottawa · CAWm. Jennings Bryan Dorn VA Medical Center · USAmgen (United States) · USJacobi Medical Center · USSt. Francis Medical Center · US

Funding

Training In Multi-modality Molecular & Translational Cardiovascular ImagingT32HL098069 · NHLBI · YALE UNIVERSITY · PI JAMES S DUNCAN, Georges El Fakhri · 2010 to 2026
$5.2M
Image Guided Delivery of Bioresponsive HydrogelsR01HL137365 · NHLBI · YALE UNIVERSITY · PI BURDICK, JASON A, DUNCAN, JAMES S · 2018 to 2021
$3.2M
Molecular Imaging Predicts Atrial Remodeling and Fibrillation VulnerabilityR01HL113352 · NHLBI · YALE UNIVERSITY · PI AKAR, JOSEPH GABRIEL, SINUSAS, ALBERT J · 2013 to 2016
$2.8M
Imaging of MMP activation and myocardial strainsR01HL078650 · NHLBI · YALE UNIVERSITY · PI SINUSAS, ALBERT J · 2004 to 2007
$2.3M
Therapeutic Targeting of Tissue Inhibitor-4 in Hypertrophy and FailureR01HL130972 · NHLBI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI SPINALE, FRANCIS G · 2016 to 2019
$1.9M
Proteolytic Imaging of Remodeling MyocardiumR42HL131280 · NHLBI · MICRO VIDE, LLC · PI SPINALE, FRANCIS G · 2016 to 2018
$1.8M
Hybrid Volumetric SPECT/CT Imaging SystemS10RR025555 · NCRR · YALE UNIVERSITY · PI SINUSAS, ALBERT J · 2009 to 2009
$500k
BLRD VA I01 BX000168NCRR NIH HHS S10 RR025555NHLBI NIH HHS R01 HL078650NHLBI NIH HHS R01 HL113352NHLBI NIH HHS R01 HL130972NHLBI NIH HHS R01 HL137365NHLBI NIH HHS R42 HL131280NHLBI NIH HHS T32 HL098069
6 · The paper itself

Abstract

backgroundThe induction of matrix metalloproteinases (MMPs) and reduction in tissue inhibitors of MMPs (TIMPs) plays a role in ischemia/reperfusion (I/R) injury post-myocardial infarction (MI) and subsequent left ventricular remodeling. We developed a hybrid dual isotope single-photon emission computed tomography/computed tomography approach for noninvasive evaluation of regional myocardial MMP activation with

methodsStudies were performed in control pigs (n=5) and pigs following 90-minute balloon occlusion-induced ischemia/reperfusion (I/R) of left anterior descending artery (n=9). Before reperfusion, pigs with I/R were randomly assigned to intracoronary infusion of rTIMP-3 (1.0 mg/kg; n=5) or saline (n=4). Three days post-I/R, dual isotope imaging was performed with

resultsThe ischemic to nonischemic ratio of

conclusionsWe have established a novel hybrid single-photon emission computed tomography/computed tomography imaging approach for the quantitative assessment of regional MMP activation, myocardial blood flow, and cardiac function post-I/R that can be used to evaluate therapeutic interventions such as intracoronary delivery of rTIMP-3 for reduction of I/R injury in the early phases of post-MI remodeling.

Indexed as

Heart VentriclesMatrix MetalloproteinasesMyocardial InfarctionMyocardiumSingle Photon Emission Computed Tomography Computed TomographyVentricular Function, LeftVentricular RemodelingAnimalsCoronary CirculationDisease Models, AnimalMaleSwineMatrix Metalloproteinasesballoon occlusionmatrix metalloproteinasesmyocardial infarctionreperfusion injuryventricular remodeling

Identifiers

PMID31707811
PMCPMC7250243
OpenAlexW2986192434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.